Oncotelic Therapeutics (OTLC) Stock Chart & Stock Price History → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free OTLC Stock Alerts $0.04 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Oncotelic Therapeutics Stock Price Performance5 Day Performance-2.37%1 Month Performance-3.13%3 Month Performance+1.92%6 Month Performance-4.04%Year-To-Date Performance-3.01%1 Year Performance+16.67% Receive OTLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProDo This Before July 30 2024 To Claim Trump’s Gift In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. OTLC Stock Chart for Sunday, June, 2, 2024 OTLC Chart by TradingView Oncotelic Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.04$0.04-4.87%$0.04$0.0455,500 shs$15.07 million05/30/2024$0.04$0.04+5.41%$0.04$0.04112,391 shs$15.85 million05/29/2024$0.04$0.04-2.63%$0.04$0.0471,000 shs$15.03 million05/28/2024$0.04$0.04+2.70%$0.04$0.0411,736 shs$15.44 million05/27/2024$0.04$0.04$0.04$0.04265,500 shs$15.03 million05/24/2024$0.04$0.04+2.78%$0.04$0.04265,500 shs$15.03 million Get the Latest News and Ratings for OTLC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.04$0.04-1.64%$0.04$0.04101,040 shs$14.63 million05/22/2024$0.04$0.04-3.02%$0.04$0.04245,079 shs$14.59 million05/21/2024$0.04$0.04-2.73%$0.04$0.04238,001 shs$15.05 million05/20/2024$0.04$0.04+2.11%$0.04$0.04125,887 shs$15.47 million05/17/2024$0.04$0.04+1.33%$0.04$0.04106,436 shs$15.15 million05/16/2024$0.04$0.04+4.17%$0.04$0.041,535 shs$14.95 million05/15/2024$0.04$0.04-7.69%$0.04$0.0458,266 shs$14.35 million05/14/2024$0.04$0.04+1.17%$0.04$0.0410,475 shs$15.55 million05/13/2024$0.04$0.04+0.78%$0.04$0.0434,000 shs$15.37 million05/10/2024$0.04$0.04-1.29%$0.04$0.0433,032 shs$15.25 million05/09/2024$0.04$0.04-1.65%$0.04$0.041,022 shs$15.45 million05/08/2024$0.04$0.04+4.79%$0.04$0.045,064 shs$15.71 million05/07/2024$0.04$0.04-1.05%$0.04$0.04535 shs$14.99 million05/06/2024$0.04$0.04-3.55%$0.04$0.042,501 shs$15.15 million05/03/2024$0.04$0.04+2.87%$0.04$0.0421,310 shs$15.71 million05/02/2024$0.04$0.04-1.29%$0.04$0.04505 shs$15.27 million05/01/2024$0.04$0.04-2.88%$0.04$0.041,267 shs$15.47 million04/30/2024$0.04$0.04-4.88%$0.04$0.0493,465 shs$15.93 million04/29/2024$0.04$0.04$0.04$0.049,635 shs$16.74 million04/26/2024$0.04$0.04+2.94%$0.04$0.0422,308 shs$16.74 million04/25/2024$0.04$0.04+7.37%$0.04$0.0410,259 shs$16.27 million04/24/2024$0.04$0.04+5.56%$0.04$0.045,509 shs$15.15 million04/23/2024$0.04$0.04-8.63%$0.04$0.041,174 shs$14.35 million04/22/2024$0.04$0.04$0.04$0.043,500 shs$15.71 million04/19/2024$0.04$0.04-6.19%$0.04$0.0435,004 shs$15.71 million04/18/2024$0.04$0.04+2.69%$0.04$0.04104,764 shs$16.74 million04/17/2024$0.04$0.04-0.49%$0.04$0.0461,129 shs$16.31 million04/16/2024$0.04$0.04$0.04$0.0420,600 shs$16.39 million04/15/2024$0.04$0.04+0.24%$0.04$0.0412,750 shs$16.39 million04/12/2024$0.04$0.04$0.04$0.0425,025 shs$16.35 million04/11/2024$0.04$0.04$0.04$0.0439,869 shs$16.35 million04/10/2024$0.04$0.04-1.44%$0.04$0.0453,601 shs$16.35 million04/09/2024$0.04$0.04-0.95%$0.04$0.04522,365 shs$16.59 million04/08/2024$0.04$0.04+5.00%$0.04$0.0411,394 shs$16.74 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/05/2024$0.04$0.04+10.51%$0.04$0.04330,773 shs$16.35 million04/04/2024$0.04$0.04+4.51%$0.04$0.0484,600 shs$14.79 million04/03/2024$0.04$0.04+0.57%$0.04$0.046,512 shs$14.15 million04/02/2024$0.04$0.04-9.25%$0.04$0.031,500 shs$14.07 million04/01/2024$0.04$0.04+8.12%$0.04$0.0449,491 shs$15.51 million03/29/2024$0.04$0.04-0.06%$0.04$0.0374,470 shs$14.34 million03/28/2024$0.04$0.04$0.04$0.0312,017 shs$14.35 million03/27/2024$0.04$0.04-8.86%$0.04$0.0412,017 shs$14.35 million03/26/2024$0.04$0.04+7.63%$0.04$0.0356,834 shs$15.75 million03/25/2024$0.04$0.04+0.14%$0.04$0.031,622 shs$14.63 million03/22/2024$0.04$0.04-2.01%$0.04$0.0320,642 shs$14.61 million03/21/2024$0.04$0.04+0.54%$0.04$0.0323,900 shs$14.91 million03/20/2024$0.04$0.04+2.48%$0.04$0.0364,074 shs$14.83 million03/19/2024$0.04$0.04+3.71%$0.04$0.0342,816 shs$14.47 million03/18/2024$0.04$0.04-5.66%$0.04$0.03319,464 shs$13.95 million03/15/2024$0.04$0.04-11.67%$0.04$0.0417,175 shs$14.79 million03/14/2024$0.04$0.04+10.53%$0.04$0.045,009 shs$16.72 million03/13/2024$0.04$0.04-9.52%$0.04$0.048,500 shs$15.13 million03/12/2024$0.04$0.04$0.04$0.0422,500 shs$16.72 million03/11/2024$0.04$0.04$0.04$0.0425 shs$16.72 million03/08/2024$0.04$0.04+11.11%$0.04$0.0490,533 shs$16.72 million03/07/2024$0.04$0.04+0.27%$0.04$0.0416,932 shs$15.05 million03/06/2024$0.04$0.04-5.75%$0.04$0.0425,085 shs$15.01 million03/05/2024$0.04$0.04$0.04$0.0456,133 shs$15.93 million03/04/2024$0.04$0.04+9.89%$0.04$0.0310,693 shs$15.93 million03/01/2024$0.04$0.04+3.12%$0.04$0.03127,380 shs$14.49 million Related Companies: IMMX Stock Price Chart THTX Stock Price Chart CALC Stock Price Chart LPTX Stock Price Chart RPHM Stock Price Chart BLRX Stock Price Chart ETST Stock Price Chart CARM Stock Price Chart RMTI Stock Price Chart AEON Stock Price Chart Receive OTLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:OTLC) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncotelic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.